---
figid: PMC9461128__13578_2022_891_Fig3_HTML
figtitle: 'Regulatory role of AP-2B in monoaminergic neurotransmitter systems: insights
  on its signalling pathway, linked disorders and theragnostic potential'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
- Human papillomavirus
- Matthiola incana
- NA
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC9461128
filename: 13578_2022_891_Fig3_HTML.jpg
figlink: /pmc/articles/PMC9461128/figure/Fig3/
number: F3
caption: 'The signalling pathway of AP-2β on catecholaminergic transmission where
  ''–'' symbolizes repressing and ''+ '' activating effect of AP-2β on the transcription
  of its target genes. AP-2β stimulate the expression of key genes involved in catecholamine
  synthesis such as TH [, , ], DBH [, , , , ], PNMT [, –] while it lowers genes coding
  catecholamine degrading enzymes such as MAO [, –] and COMT [, ]. AP-2β also repress
  the transcription of DRD1A through binding to its D1AS1 []. AP-2β: transcription
  activating protein 2 beta; TH: tyrosine hydroxylase; DBH: dopamine-beta-hydroxylase;
  PNMT: phenylethanolamine N-methyltransferase; MAO: monoamine oxidase; COMT: catechol-O-methyltransferase;
  HVA: homovanillic acid; VMA: 3-methoxy-4-hydroxymandelic acid; MHPG: 3- methoxy-4-hydroxy-phenylglycol;
  D1AS1: dopamine receptor 1A silencer 1; DRD1A: dopamine receptor 1A; AC: adenylyl
  cyclase; and cAMP: cyclic adenosine monophosphate'
papertitle: 'The regulatory role of AP-2β in monoaminergic neurotransmitter systems:
  insights on its signalling pathway, linked disorders and theragnostic potential.'
reftext: Mohamed H. Al-Sabri, et al. Cell Biosci. 2022;12:151.
year: '2022'
doi: 10.1186/s13578-022-00891-7
journal_title: Cell & Bioscience
journal_nlm_ta: Cell Biosci
publisher_name: BioMed Central
keywords: Transcription factor AP-2 beta | AP-2β | TFAP2Β | Monoaminergic neurotransmitter
  systems | Dopamine | Noradrenaline | Serotonin | Monoamine neurotransmitter disorders
  | Polymorphisms | Obesity | Neuroblastoma | Diagnostic biomarker and therapeutic
  target
automl_pathway: 0.9459582
figid_alias: PMC9461128__F3
figtype: Figure
redirect_from: /figures/PMC9461128__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9461128__13578_2022_891_Fig3_HTML.html
  '@type': Dataset
  description: 'The signalling pathway of AP-2β on catecholaminergic transmission
    where ''–'' symbolizes repressing and ''+ '' activating effect of AP-2β on the
    transcription of its target genes. AP-2β stimulate the expression of key genes
    involved in catecholamine synthesis such as TH [, , ], DBH [, , , , ], PNMT [,
    –] while it lowers genes coding catecholamine degrading enzymes such as MAO [,
    –] and COMT [, ]. AP-2β also repress the transcription of DRD1A through binding
    to its D1AS1 []. AP-2β: transcription activating protein 2 beta; TH: tyrosine
    hydroxylase; DBH: dopamine-beta-hydroxylase; PNMT: phenylethanolamine N-methyltransferase;
    MAO: monoamine oxidase; COMT: catechol-O-methyltransferase; HVA: homovanillic
    acid; VMA: 3-methoxy-4-hydroxymandelic acid; MHPG: 3- methoxy-4-hydroxy-phenylglycol;
    D1AS1: dopamine receptor 1A silencer 1; DRD1A: dopamine receptor 1A; AC: adenylyl
    cyclase; and cAMP: cyclic adenosine monophosphate'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Drd1
  - ac
  - Th
  - Ddc
  - da
  - Maob
  - Maoa
  - Comt
  - Dbh
  - Pnmt
  - ATP8A2
  - DRD1
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - TH
  - DDC
  - MAOB
  - MAOA
  - COMT
  - DBH
  - PNMT
  - PEMT
  - ATPsynbeta
  - Atpalpha
  - nAChRalpha2
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - comt
  - Tbh
  - drd1a
  - th
  - mao
  - comta
  - dbh
---
